The rise of Autism Spectrum Disorder (ASD) is associated with increased cannabis exposure in a large US case controlled study that reflect a causation. https://www.longdom.org/open-access/epidemiological-associations-of-various-substances-and-multiple-cannabinoids-with-autism-in-usa.pdf
Parental cannabis use has been associated with adverse neurodevelopmental outcomes in offspring, but how such phenotypes are transmitted is largely unknown. Using reduced representation bisulphite sequencing (RRBS), we recently demonstrated that cannabis use is associated with widespread DNA methylation changes in human and rat sperm. Discs-Large Associated Protein 2 (DLGAP2), involved in synapse organization, neuronal
Cannabis cannot be safely recommended for the treatment of Autism or ADHD according to Harvard physicians.
Most Recent News
Cannabis vaping is increasing as the most popular method of cannabis delivery among all adolescents in the U.S., as is the frequency of cannabis vaping, according to research at Columbia University Mailman School of Public Health. The study found that the frequency of vaping cannabis among adolescents from all demographic groups is reported at six
The legal status of Cannabis is changing, fueling an increasing diversity of Cannabis-derived products. Because Cannabis contains dozens of chemical compounds with potential psychoactive or medicinal effects, understanding this phytochemical diversity is crucial. The legal Cannabis industry heavily markets products to consumers based on widely used labeling systems purported to predict the effects of different
THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not
On about 600 occasions in 2019, state marijuana industry regulators sent hired operatives, aged 18 to 20, into Colorado dispensaries to check that the law barring sales to people under 21 was being followed. Then the COVID-19 pandemic hit, and in 2020 state regulators reported only 118 of those checks. Last year, the number dropped